Literature DB >> 15900593

Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas.

Natacha Entz-Werlé1, Corinne Stoetzel, Perrine Berard-Marec, Chantal Kalifa, Laurence Brugiere, Hélène Pacquement, Claudine Schmitt, Marie-Dominique Tabone, Jean-Claude Gentet, Robert Quillet, Pierre Oudet, Patrick Lutz, Annie Babin-Boilletot, Marie-Pierre Gaub, Fabienne Perrin-Schmitt.   

Abstract

The identification of genes as markers for chromosome aberrations in specific tumors might facilitate oncogenesis mechanism comprehension, cancer detection, prediction of clinical outcomes, and response to therapy. Previous physiologic and oncologic data identified the TWIST gene as a marker for mesodermal derivative and bone tissue differentiation, but its contribution to bone malignancies has not been investigated. In the present study, search for genomic alterations in high-grade pediatric osteosarcomas was focused on the 7p21 region, and more specifically on the TWIST gene. In a cohort of 74 patients, we observed by allelotyping that 31 of 68 informative tumors were rearranged at the TWIST locus. Among them, analysis by quantitative PCR (QPCR) revealed that, surprisingly, mostly deletions (22/68), but also amplifications (9/68), of the TWIST gene were detected. Furthermore, deletions at TWIST were statistically correlated to other molecular abnormalities, like alterations at the APC or c-kit loci, as well as to clinical features such as a poor outcome. This work shows that the TWIST gene seemed to be involved in high-grade pediatric osteosarcomas and is a new marker with a possible initial predictive value. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900593     DOI: 10.1002/ijc.21068

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Nonsyndromic brachydactyly type D and type E mapped to 7p15 in healthy children and adults from the Jirel ethnic group in eastern Nepal.

Authors:  Kimberly D Williams; John Blangero; Janardan Subedi; Bharat Jha; Thomas Dyer; John L Vandeberg; Bradford Towne; Sarah Williams-Blangero
Journal:  Am J Hum Biol       Date:  2013-09-10       Impact factor: 1.937

2.  Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.

Authors:  Yi Guo; Jun Xie; Elyssa Rubin; Ya-Xiong Tang; Fritz Lin; Xiaolin Zi; Bang H Hoang
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

3.  Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors:  Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal:  Med Oncol       Date:  2012-07-31       Impact factor: 3.064

4.  TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.

Authors:  G Yin; R Chen; A B Alvero; H-H Fu; J Holmberg; C Glackin; T Rutherford; G Mor
Journal:  Oncogene       Date:  2010-04-19       Impact factor: 9.867

5.  TWIST1 Gene: First Insights in Felis catus.

Authors:  Cláudia S Baptista; Estela Bastos; Sara Santos; Ivo G Gut; Henrique Guedes-Pinto; Fátima Gärtner; Raquel Chaves
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

6.  Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.

Authors:  Ken Sasaki; Shoji Natsugoe; Sumiya Ishigami; Masataka Matsumoto; Hiroshi Okumura; Tetsuro Setoyama; Yasuto Uchikado; Yoshiaki Kita; Kiyokazu Tamotsu; Akihiko Sakamoto; Tetsuhiro Owaki; Takashi Aikou
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21

7.  Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.

Authors:  Sung-Im Do; Ji Yeon Kim; So Young Kang; Jae Joon Lee; Jeong Eon Lee; Seok Jin Nam; Eun Yoon Cho
Journal:  Tumour Biol       Date:  2012-11-14

8.  Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma.

Authors:  Rhamy Zeid; Matthew A Lawlor; Evon Poon; Jaime M Reyes; Mariateresa Fulciniti; Michael A Lopez; Thomas G Scott; Behnam Nabet; Michael A Erb; Georg E Winter; Zoe Jacobson; Donald R Polaski; Kristen L Karlin; Rachel A Hirsch; Nikhil P Munshi; Thomas F Westbrook; Louis Chesler; Charles Y Lin; James E Bradner
Journal:  Nat Genet       Date:  2018-01-29       Impact factor: 38.330

Review 9.  Translational biology of osteosarcoma.

Authors:  Maya Kansara; Michele W Teng; Mark J Smyth; David M Thomas
Journal:  Nat Rev Cancer       Date:  2014-10-16       Impact factor: 60.716

10.  Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis.

Authors:  Natacha Entz-Werle; Thomas Lavaux; Nadia Metzger; Corinne Stoetzel; Christelle Lasthaus; Perrine Marec; Chantal Kalifa; Laurence Brugieres; Hélène Pacquement; Claudine Schmitt; Marie-Dominique Tabone; Jean-Claude Gentet; Patrick Lutz; Annie Babin; Pierre Oudet; Marie Pierre Gaub; Fabienne Perrin-Schmitt
Journal:  Neoplasia       Date:  2007-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.